COVID-19

Head and Neck Cancers

Questions discussed in this category

Is the COVID-19 pandemic affecting your choice of high dose versus weekly cisplatin for definitive concurrent chemoradiation for HPV negative head and neck cancer?

1 Answer available

How will your management of head and neck cancers change with the COVID-19 pandemic?

Are you employing more or less primary chemoRT v. surgery for some cancers? Are you dose de-escalating? What are issues radiation oncologists should b...

6 Answers available

Are you covering the tracheostomy site with a surgical mask due to COVID-19 to protect the therapist?

Please see this article for referrence https://www.sciencedirect.com/science/article/pii/S0167814020301638

1 Answer available

In the wake of the COVID-19 pandemic, are there any hypofractionated regimens (without concurrent chemotherapy) that could be utilized for head /neck cancer in a post operative setting?

2 Answers available

How should you manage a coronavirus infected/suspected patient who is receiving radiotherapy and cannot interrupt or delay their cancer treatment?

How would you approach a patient who is receiving chemoRT but has confirmed COVID-19 with minor symptoms, as breaking treatment for 2 weeks quarantine...

7 Answers available

Papers discussed in this category

Int. J. Radiat. Oncol. Biol. Phys.,

A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck.

Int. J. Radiat. Oncol. Biol. Phys., 2019 Feb 16

Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.

COVID-19

Head and Neck Cancers

Questions discussed in this category

Papers discussed in this category

Related Topics in COVID-19